Top 5 Medical Device Angel Investors in Belgium
A list of 5 angel investors that invest in Medical device startups based in Belgium. We rank investors based on the number of investments they made in Medical device companies from Belgium. We update this investor list every month.Top 5 Medical Device Angel Investors in Belgium
Investor | Medical Device Belgium investments |
---|---|
Pierre Rigaux | 3 |
Jean Dessain | 1 |
Eduardo Ronzano | 1 |
Yves Beudin | 1 |
Pierre Drion | 1 |
Pierre Rigaux
Show more
Investment focus
- Sports, Medical Device
- Seed, Pre-Seed, Convertible Note
- Belgium
Portfolio highlights
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Eduardo Ronzano is the Founder of KelDoc.
Show more
Investment focus
- Software, SaaS, E-Commerce
- Seed, Pre-Seed, Angel
- France, United States, United Kingdom
Portfolio highlights
- Screeb — Make products your users will love by using Screeb, the all-in-one tool for Product Discovery. Product analytics, user recruitment, and more!
- Spades — Guests Scan a QR code to view the menu and Pay, they can also Split the amount and Tip the staff. Now faster than ever.
- Morpho Labs — Morpho is an on-chain peer-to-peer layer on top of lending pools. Rates are seamlessly improved for borrowers and lenders while preserving the same guarantees. Morpho combines the efficiency of P2P with the liquidity of lending pools. Users enjoy an improved APY while maintaining the pool’s flexibility
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Investors by industry
Health Care
Biotech
Community
Marketplace
FinTech
Impact
Proptech
Media (entertainment)
EdTech
Consumer
Climate
Energy
Hardware
Gaming
Artificial intelligence
Sustainability
Agriculture (agtech)
Venture Capital
Restaurants
Publishing
Beauty
Oil and Gas
Web3
Video Games
Food and Beverage
Clean Energy
Real Estate
Infrastructure
Big Data
Organic Food
Photography
Fashion
Education
B2B
Medical
Email
Wellness
Social Media
Renewable Energy
Music
Franchise
Celebrity
Android
Internet
Legal
Google
eSports
Construction
Local
Mobile
Enterprise Software
Sports
Social Network
Manufacturing
Digital Media
Facebook
Art
Social Impact
Recruiting
Platforms
Travel
Fitness
Mobile Advertising
Cannabis
Biotechnology
Hospitality
Payments
Automotive
Crowdfunding
Wine And Spirits
Medical Device
Social
CleanTech
Financial Services
Transportation
Mobile Apps
Sporting Goods
InsurTech
Enterprise
Finance
Retail
Film
LGBT
Life Science
Theatre
SaaS
Non Profit
Cryptocurrency
Software
Blockchain
Investors by country
Canada
United Kingdom
Ireland
Germany
South Korea
Australia
United States
India
New Zealand
Oceania
Armenia
China
Europe
Indonesia
LATAM
Middle East
Spain
Asia
Japan
South Africa
Qatar
Vietnam
Saudi Arabia
Singapore
Sri Lanka
Brazil
Africa
Czech Republic
Bahrain
Belize
Bermuda
Costa Rica
Belarus
Kuwait
Israel
Jersey
Kazakhstan
Nicaragua
Philippines
Italy
Mali
Lithuania
Cambodia
Liechtenstein
Kenya
Liberia
Lebanon
Mauritius
Morocco
Malaysia
Norway
Peru
Myanmar
Cayman Islands
Panama
Malta
Mexico
Seychelles
Slovenia
Russian Federation
Rwanda
Serbia
Uzbekistan
Togo
Taiwan
Ukraine
Sierra Leone
Turkey
Tunisia
Thailand
Tajikistan
Poland
Uganda
Zimbabwe
Tanzania
San Marino
Uruguay
Venezuela
Zambia
Senegal
Puerto Rico
Portugal
Sweden
El Salvador
Nigeria
Bahamas
Azerbaijan
Iraq
Iceland
Namibia
United Arab Emirates
Honduras
Isle of Man
Bolivia
Luxembourg
Pakistan
Albania
Bulgaria
Argentina
Bangladesh
Grenada
Jordan
Romania
Austria
Denmark
Algeria
Georgia
Gibraltar
Cameroon
Chile
Finland
Estonia
Faroe Islands
Greece
Ethiopia
Ghana
Hungary
Croatia
Egypt
Belgium
Barbados
Ecuador
France
Hong Kong
Cyprus
Latvia
Oman
Switzerland
Colombia
Guatemala
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Media (entertainment)
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Mobile
Software
Sports
Enterprise Software
Automotive
FinTech
Hospitality
Platforms
Enterprise
Health Care
Biotech
Community
Climate
Proptech
SaaS
Artificial intelligence
Gaming
Real Estate
Transportation
Publishing
Retail
Payments
Hardware
Construction